ArticleNeuropsychiatric disease and treatment2025
Construction and Brain Validation of circRNAs-miRNAs-mRNAs Regulatory Axis in Early-Onset Schizophrenia.
Article in Neuropsychiatric disease and treatment, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- From Transcriptome to Therapy: The ncRNA Revolution in Neurodevelopmental Disorders.Brain sciences · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: High rates of misdiagnosis and missed diagnosis of schizophrenia highlight the urgent need for objective diagnostic indicators. Previous studies showed that microRNAs and circular RNAs are potential candidates. This study aimed to investigate the regulatory patterns and brain validation of circular RNAs-microRNAs-messenger RNAs in early-onset schizophrenia. Methods: Differentially expressed circular RNAs and microRNAs were identified in blood samples from 32 patients with early-onset schizophrenia and 29 healthy controls. Circular RNAs were confirmed to possess circular structures. The interactions among circular RNAs, microRNAs, and messenger RNAs were examined using dual-luciferase reporter assays. The circRNA of interest was knocked down and overexpressed in the SH-SY5Y cell line to evaluate changes in gene expression. Brain validation of the axis was performed in animal models. Results: Compared with healthy controls, 8 circular RNAs and 3 microRNAs exhibited significant and stable differential expression, with 6 of the 8 circular RNAs confirmed to have circular structures. Hsa-circ-0000713 was identified as containing the response element for hsa-miR-370-3p, which targeted ANK3 and MGLL. Hsa-circ-0000713 acted as a sponge, mitigating the inhibitory effects of hsa-miR-370-3p on ANK3 and MGLL. The expression patterns of this axis in the prefrontal cortex were consistent with those observed in peripheral blood samples from clinical patients. Conclusion: This study identified a specific multi-molecular axis in early-onset schizophrenia, wherein hsa-circ-0000713 functioned as a sponge to reduce the inhibitory effects of hsa-miR-370-3p on ANK3 and MGLL. This axis may contribute to the pathogenesis of early-onset schizophrenia by mediating abnormalities in prefrontal cortex development.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.